High-Throughput Fluorescence Assays for Ion Channels and GPCRs

Author(s):  
Irina Vetter ◽  
David Carter ◽  
John Bassett ◽  
Jennifer R. Deuis ◽  
Bryan Tay ◽  
...  
2015 ◽  
Vol 37 (1) ◽  
pp. 34-43 ◽  
Author(s):  
Hai-bo Yu ◽  
Min Li ◽  
Wei-ping Wang ◽  
Xiao-liang Wang

2010 ◽  
Vol 5 (10) ◽  
pp. 995-1006 ◽  
Author(s):  
Shephali Trivedi ◽  
Jay Liu ◽  
Ruifeng Liu ◽  
Robert Bostwick

2014 ◽  
Vol 106 (2) ◽  
pp. 623a
Author(s):  
Ekaterina Zaitseva ◽  
Liviu Movileanu ◽  
Bert van den Berg ◽  
Frank Bernhard ◽  
Christopher Hein ◽  
...  

2020 ◽  
Author(s):  
Nina Braun ◽  
Søren Friis ◽  
Christian Ihling ◽  
Andrea Sinz ◽  
Jacob Andersen ◽  
...  

AbstractIncorporation of non-canonical amino acids (ncAAs) can endow proteins with novel functionalities, such as crosslinking or fluorescence. In ion channels, the function of these variants can be studied with great precision using standard electrophysiology, but this approach is typically labor intensive and low throughput. Here, we establish a high-throughput protocol to conduct functional and pharmacological investigations of ncAA-containing hASIC1a (human acid-sensing ion channel 1a) variants in transiently transfected mammalian cells. We introduce three different photocrosslinking ncAAs into 103 positions and assess the function of the resulting 309 variants with automated patch-clamp (APC). We demonstrate that the approach is efficient and versatile, as it is amenable to assessing even complex pharmacological modulation by peptides. The data show that the acidic pocket is a major determinant for current decay and live-cell crosslinking provides insight into the hASIC1a-psalmotoxin-1 interaction. Overall, this protocol will enable future APC-based studies of ncAA-containing ion channels in mammalian cells.


2003 ◽  
Vol 8 (6) ◽  
pp. 660-667 ◽  
Author(s):  
Paul Burnett ◽  
Janet K. Robertson ◽  
Jeffrey M. Palmer ◽  
Richard R. Ryan ◽  
Adrienne E. Dubin ◽  
...  

Designing high-throughput screens for voltage-gated ion channels has been a tremendous challenge for the pharmaceutical industry because channel activity is dependent on the transmembrane voltage gradient, a stimulus unlike ligand binding to G-protein-coupled receptors or ligand-gated ion channels. To achieve an acceptable throughput, assays to screen for voltage-gated ion channel modulators that are employed today rely on pharmacological intervention to activate these channels. These interventions can introduce artifacts. Ideally, a high-throughput screen should not compromise physiological relevance. Hence, a more appropriate method would activate voltage-gated ion channels by altering plasma membrane potential directly, via electrical stimulation, while simultaneously recordingthe operation of the channel in populations of cells. The authors present preliminary results obtained from a device that is designed to supply precise and reproducible electrical stimuli to populations of cells. Changes in voltage-gated ion channel activity were monitored using a digital fluorescent microscope. The prototype electric field stimulation (EFS) device provided real-time analysis of cellular responsiveness to physiological and pharmacological stimuli. Voltage stimuli applied to SK-N-SH neuroblastoma cells cultured on the EFS device evoked membrane potential changes that were dependent on activation of voltage-gated sodium channels. Data obtained using digital fluorescence microscopy suggests suitability of this system for HTS.


Sign in / Sign up

Export Citation Format

Share Document